Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine Growth Hormone for Thin Endometrium in FET
NCT06379659Phase 2Completed
- Start
- May 2024
- Primary completion
- Jul 2024
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of somatropin in thin endometrium. Started May 2024; status: completed.
02
Drugs
somatropin
03
Conditions
thin endometrium
Beyond the preview
Go deeper on NCT06379659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06379659.